Micro Labs Limited Rivaroxaban Export Data — India (DGFT 2022–2026)

Name: Micro Labs Limited Rivaroxaban Export Records India — #5 Exporter, 141 Shipments, $2.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rivaroxaban

India Pharmaceutical Trade Intelligence

$52.6M221 Suppliers115 CountriesHS 30049099

ExportsIndia → NETHERLANDS29.9%India → MALTA9.6%

ImportsGERMANY → India$34.1B CANADA → India$46.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Micro Labs Limited — Rivaroxaban Exporter #5 | $2.4M Trade Value | TransData Nexus | TransData Nexus

Micro Labs Limited — Rivaroxaban Exporter Profile

Indian Pharmaceutical Exporter · #5 for Rivaroxaban · $2.4M export value · DGFT Verified

Micro Labs Limited is the #5 Indian exporter of Rivaroxaban with $2.4M in export value and 141 verified shipments. Micro Labs Limited holds a 4.5% market share in Rivaroxaban exports across 20 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.

Micro Labs Limited — Rivaroxaban Export Profile: Buyers & Destinations

Micro Labs Limited Rivaroxaban export treemap — buyers and destination countries | TransData Nexus

Where Does Micro Labs Limited Export Rivaroxaban?

Country	Value	Shipments	Share
FRANCE	$373.9K	22	19.6%
TANZANIA	$207.3K	12	10.8%
UNITED KINGDOM	$181.6K	8	9.5%
MADAGASCAR	$180.3K	13	9.4%
UGANDA

Who Are the Top Buyers of Rivaroxaban from Micro Labs Limited?

Buyer	Country	Value	Orders
E.P.DIS	FRANCE	$241.8K	16
LABOREX TANZANIA LTD	TANZANIA	$198.4K	11
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$181.6K	8
HAWKARY PHARMACEUTICAL COMPANY#	IRAQ	$150.0K	3
M/S LABOREX KENYA LIMITED	KENYA	$148.8K	6
MICRO NOVA PHARMACEUTICALS IND	NIGERIA	$119.5K	3
E P DIS	FRANCE	$115.2K	5
FTM (MAURITIUS) LIMITED	MAURITIUS	$102.5K	15
SOMAPHAR	MADAGASCAR	$93.1K	5
VIVA HEALTHCARE CO LIMITED	THAILAND	$81.9K	3

Micro Labs Limited supplies Rivaroxaban to 37 buyers globally. The largest buyer is E.P.DIS (FRANCE), followed by LABOREX TANZANIA LTD (TANZANIA) and BROWN AND BURK UK LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Rivaroxaban Formulations Does Micro Labs Limited Export?

Product Description / Formulation	Value	Shipments
VAROXA 20(RIVAROXABAN 20MG TABLETS)3X10'	$68.8K	2
VAROXA 10(RIVAROXABAN 10MG TABLETS)3X10'	$61.7K	2
RIVAROXABAN MICRO 15(RIVAROXABAN TABLETS	$50.0K	1
RIVAROXABAN MICRO 20(RIVAROXABAN TABLETS	$50.0K	1
RIVAROXABAN MICRO 10(RIVAROXABAN TABLETS	$50.0K	1
VAROXA 20 RIVAROXABAN TABLETS 20MG3x10`S QTY-8155TAX DOCUMENT NO:712202658/30.09.2023	$50.0K	1
VAROXA 15 (RIVAROXABAN TABLETS 15MG) ( 3X10`S ) ( QTY- 19940.000 ) TAX INV NO: 701209691/09.01.2025	$50.0K	1
RIVAROX - 20 (RIVAROXABAN TABLETS 20MG)(3X10'S)( QTY- 8309.00 ) TAX INV NO: 706205519/01.07.2024	$50.0K	1
VAROXA 10 (RIVAROXABAN TABLETS 10MG) 3X10'S ( QTY- 8448) TAX INV NO: 712203075/08.07.2024	$50.0K	1
VAROXA 10 (RIVAROXABAN TABLETS 10MG) (3X10`S) (QTY-16176.000) TAX INV NO: 701209973/24.03.2025	$50.0K	1

Micro Labs Limited exports 126 distinct Rivaroxaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VAROXA 20(RIVAROXABAN 20MG TABLETS)3X10' with 2 shipments worth $68.8K.

How Does Micro Labs Limited Compare to Nearest Rivaroxaban Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	DR.REDDY'S LABORATORIES LTD	$5.2M	131	12	$39.6K
3	ZENTIVA PRIVATE LIMITED	$3.2M	148	2	$21.5K
5	MICRO LABS LIMITED ★	$2.4M	141	20	$16.9K
6	APOTEX RESEARCH PRIVATE LIMITED	$2.3M	54	1	$42.1K
7	TORRENT PHARMACEUTICALS LTD	$2.1M	59	5	$35.8K

Micro Labs Limited ranks #5 among 221 Indian Rivaroxaban exporters. Average shipment value of $16.9K compared to the market average of $166.0K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and ZENTIVA PRIVATE LIMITED.

Which Indian Ports Ship Rivaroxaban Exports?

Port	Shipments	% Share
SAHAR AIR	1,144	21.3%
DELHI AIR CARGO ACC (INDEL4)	985	18.4%
DELHI AIR	659	12.3%
SAHAR AIR CARGO ACC (INBOM4)	635	11.8%
Bombay Air	197	3.7%
NHAVA SHEVA SEA (INNSA1)	164	3.1%
Delhi Air	133	2.5%
HYDERABAD AIR	110	2.1%

Geopolitical & Trade Policy Impact on Micro Labs Limited's Rivaroxaban Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)

Micro Labs Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)

However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 142 individual customs records matching Micro Labs Limited exporting Rivaroxaban, covering 126 formulations to 21 countries via 37 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 497+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rivaroxaban

Rivaroxaban

Micro Labs Limited — Rivaroxaban Exporter Profile

Micro Labs Limited — Rivaroxaban Export Profile: Buyers & Destinations

Where Does Micro Labs Limited Export Rivaroxaban?

Who Are the Top Buyers of Rivaroxaban from Micro Labs Limited?

What Is India's Total Rivaroxaban Export Value and How Much Does Micro Labs Limited Contribute?

What Is the Average Shipment Value for Micro Labs Limited's Rivaroxaban Exports?

How Does Micro Labs Limited Compare to Other Indian Rivaroxaban Exporters?

What Rivaroxaban Formulations Does Micro Labs Limited Export?

Regulatory Requirements: Exporting Rivaroxaban to Key Markets

United Kingdom — MHRA

How Does Micro Labs Limited Compare to Nearest Rivaroxaban Exporters?

Which Indian Ports Ship Rivaroxaban Exports?

Rivaroxaban — Export Intelligence Video

Geopolitical & Trade Policy Impact on Micro Labs Limited's Rivaroxaban Exports

Micro Labs Limited — Regulatory Compliance & Quality Standards

About Micro Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rivaroxaban Export Data from Micro Labs Limited

Rivaroxaban Stats

Company Overview

Top Products by Micro Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source